<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210911052440N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-02-25</date_registration>
      <primary_sponsor>Artesh University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Otago Exercise in Sleep Quality, Fatigue and dialysis adequacy</public_title>
      <acronym></acronym>
      <scientific_title>Effectiveness of Otago Exercise on Sleep Quality, Fatigue and dialysis adequacy in Hemodialysis Patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-11-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>44</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/58681</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Other, Purpose: Supportive, Randomization description: Eligible patients based on inclusion criteria in the random allocation method using variable block method (if A: intervention group, B: control group, there will be six different modes for 4 blocks: 1. AABB 2. ABAB 3. ABBA 4. BBAA 5. BABA 6. BAAB (blocks that can be written on paper and removed from the bag) will be distributed in two groups. In this way, after explaining the method and objectives of the study to patients and, if necessary, their families and obtaining their informed consent, they are randomly assigned to two groups of intervention and control. Thus, the first patient will be in the intervention group and the second patient in the control group and will be observed in the same way until the last patient.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Adequacy of dialysis. Condition 2: Sleep quality of dialysis patients. Condition 3: Fatigue of dialysis patients.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the intervention group, first home exercise movements Otago will be taught face-to-face once or twice by the researcher to the patient and his / her companion in the hemodialysis ward to ensure complete learning (performing flawless exercise in front of the researcher). The film, the Otago Sports Training Booklet, and the researcher's mobile number will then be provided to clients for possible questions. The clients of the intervention group and their companions will be explained that this exercise should be performed by the clients undergoing hemodialysis according to the schedule, including 8 weeks and three sessions per week and one hour each day on non-hemodialysis days under the supervision of a family member.In addition, the researcher will follow the exercise through face-to-face, mobile phone, SMS and cyberspace. Intervention 2: Control group: The control group does not receive any intervention. Only at the beginning and end of the research, they are asked about demographic information and questionnaire questions. At the end of the intervention, the questionnaires in both groups will be completed and analyzed again.In addition, after the intervention, educational booklets and videos will be provided to the clients of the control group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hamid Beig Mohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran. West Fatemi Street. End of Etemadzadeh Street.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1411718541</zip>
        <telephone>+98 21 8802 8350</telephone>
        <email>hamid.f4b@gmail.com</email>
        <affiliation>Artesh University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Affat Afaqi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran. West Fatemi Street. End of Etemadzadeh Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1411718541</zip>
        <telephone>+98 21 8820 8350</telephone>
        <email>afaghi8181@gmail.com</email>
        <affiliation>Artesh University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age over 18 years and under 75 years
At least 6 months of hemodialysis treatment
Do dialysis twice or more a week
Absence of acute infection
Lack of musculoskeletal disorders such as multiple sclerosis, heart failure and severe respiratory
Absence of chronic inflammatory disease of unknown origin
Ability to perform sports movements based on the patient's own statements
Do not take sleeping pills, sedatives</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Identification of any of the problems and diseases mentioned in the inclusion criteria during the study
Reluctance to continue cooperation
Failure to perform the desired exercise program for three sessions</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Diagnosis</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the intervention group, first home exercise movements Otago will be taught face-to-face once or twice by the researcher to the patient and his / her companion in the hemodialysis ward to ensure complete learning (performing flawless exercise in front of the researcher). The film, the Otago Sports Training Booklet, and the researcher's mobile number will then be provided to clients for possible questions. The clients of the intervention group and their companions will be explained that this exercise should be performed by the clients undergoing hemodialysis according to the schedule, including 8 weeks and three sessions per week and one hour each day on non-hemodialysis days under the supervision of a family member.In addition, the researcher will follow the exercise through face-to-face, mobile phone, SMS and cyberspace.</i_keyword>
      <i_keyword>Control group: The control group does not receive any intervention. Only at the beginning and end of the research, they are asked about demographic information and questionnaire questions. At the end of the intervention, the questionnaires in both groups will be completed and analyzed again.In addition, after the intervention, educational booklets and videos will be provided to the clients of the control group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Adequacy of dialysis. Timepoint: Measurement of dialysis adequacy at the beginning of the study (before the intervention) and 8 weeks after the start. Method of measurement: According to the patient's tests and the use of two formulas Kt / V and URR.</prim_outcome>
      <prim_outcome>Sleep quality of dialysis patients. Timepoint: Measurement of sleep quality at the beginning of the study (before the intervention) and 8 weeks after the start. Method of measurement: Pittsburgh Sleep Quality Inventory (PSQI).</prim_outcome>
      <prim_outcome>Fatigue of dialysis patients. Timepoint: Measurement of fatigue at the beginning of the study (before the intervention) and 8 weeks after the start. Method of measurement: Multidimensional Fatigue Questionnaire MFI-20.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Artesh University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-06-26</approval_date>
        <contact_name>Ethics Committee of Army University of Medical Sciences</contact_name>
        <contact_address>Tehran-West Fatemi St.-End of Etemadzadeh St. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
